Rodríguez-Leor, OriolCid-Álvarez, BelénPérez de Prado, ArmandoRossello, XavierOjeda, SoledadSerrador, AnaLópez-Palop, RamónMartín-Moreiras, JavierRumoroso, José RamónCequier, ÁngelIbáñez, BorjaCruz-González, IgnacioRomaguera, RafaelMoreno, Raúlen representación de los investigadores del Grupo de Trabajo sobre Código Infarto de la Asociación de Cardiología Intervencionista de la Sociedad Española de CardiologíaVilla, ManuelRuíz-Salmerón, RafaelMolano, FranciscoSánchez, CarlosMuñoz-García, ErikaÍñigo, LuísHerrador, JuanGómez-Menchero, AntonioGómez-Menchero, AntonioCaballero, JuanOjeda, SoledadCárdenas, MéridaGheorghe, LiviaOneto, JesúsMorales, FranciscoValencia, FélixRuíz, José RamónDiarte, José AntonioAvanzas, PabloRondán, JuanPeral, VicentePernasetti, Lucía VeraHernández, JulioBosa, FranciscoLorenzo, Pedro Luís MartínJiménez, FranciscoHernández, José M de la TorreJiménez-Mazuecos, JesúsLozano, FernandoMoreu, JoséNovo, EnriqueRobles, JavierMoreiras, Javier MartínFernández-Vázquez, FelipeAmat-Santos, Ignacio JGómez-Hospital, Joan AntoniGarcía-Picart, JoanBlanco, Bruno García DelRegueiro, AnderCarrillo-Suárez, XavierTizón, HelenaMohandes, MohsenCasanova, JuanAgudelo-Montañez, VíctorMuñoz, Juan FranciscoFranco, JuanDel Castillo, RobertoSalinas, PabloElizaga, JaimeSarnago, FernandoJiménez-Valero, SantiagoRivero, FernandoOteo, Juan FranciscoAlegría-Barrero, EduardoSánchez-Recalde, ÁngelRuíz, ValerianoPinar, EduardoPinar, EduardoPlanas, AnaLedesma, Bernabé LópezBerenguer, AlbertoFernández-Cisnal, AgustínAguar, PabloPomar, FranciscoJerez, MiguelTorres, FranciscoGarcía, RicardoFrutos, AraceliNodar, Juan Miguel RuízGarcía, KoldobikaSáez, RobertoTorres, AlfonsoTellería, MirenSadaba, MarioMínguez, José Ramón LópezMerchán, Juan Carlos RamaPortales, JavierTrillo, RamiroAldama, GuillermoFernández, SaletaSantás, MelisaPérez, María Pilar Portero2025-01-072025-01-072020-10-09https://hdl.handle.net/10668/25791The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P  94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P  The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent.esCOVID-19Primary angioplastySTEMISTEMI networkresearch article33071427open access10.1016/j.recesp.2020.07.0331579-2242PMC7546233https://doi.org/10.1016/j.recesp.2020.07.033https://pmc.ncbi.nlm.nih.gov/articles/PMC7546233/pdf